252 related articles for article (PubMed ID: 32710679)
1. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement.
Khan A; Maheshwari S; Gupta K; Naseem K; Chowdry M; Singh S
J Gastroenterol Hepatol; 2021 Mar; 36(3):775-781. PubMed ID: 32710679
[TBL] [Abstract][Full Text] [Related]
2. Lower 90-day Hospital Readmission Rates for Esophageal Variceal Bleeding After TIPS: A Nationwide Linked Analysis.
Rush B; Deol N; Teriyaki A; Sey M; Jairath V; Walley KR; Celi LA; Brahmania M
J Clin Gastroenterol; 2020 Jan; 54(1):90-95. PubMed ID: 30829905
[TBL] [Abstract][Full Text] [Related]
3. Causes and Rates of 30-Day Readmissions After Transjugular Intrahepatic Portosystemic Shunts.
Sarwar A; Weinstein JL; Novack V; Chakrala N; Tapper EB; Malik R; Ahmed M
AJR Am J Roentgenol; 2020 Jul; 215(1):235-241. PubMed ID: 32374665
[No Abstract] [Full Text] [Related]
4. Outcomes of transjugular intrahepatic portosystemic shunt through the left branch vs. the right branch of the portal vein in advanced cirrhosis: a randomized trial.
Chen L; Xiao T; Chen W; Long Q; Li R; Fang D; Wang R
Liver Int; 2009 Aug; 29(7):1101-9. PubMed ID: 19386025
[TBL] [Abstract][Full Text] [Related]
5. Nationwide trends and predictors of inpatient mortality in 83884 transjugular intrahepatic portosystemic shunt.
Lee EW; Kuei A; Saab S; Busuttil RW; Durazo F; Han SH; El-Kabany MM; McWilliams JP; Kee ST
World J Gastroenterol; 2016 Jul; 22(25):5780-9. PubMed ID: 27433091
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcome and survival predictors in patients with cirrhosis after 10-mm-covered transjugular intrahepatic portosystemic shunt.
Tejedor-Tejada J; Fuentes-Valenzuela E; García-Pajares F; Nájera-Muñoz R; Almohalla-Álvarez C; Sánchez-Martín F; Calero-Aguilar H; Villacastín-Ruiz E; Pintado-Garrido R; Sánchez-Antolín G
Gastroenterol Hepatol; 2021 Nov; 44(9):620-627. PubMed ID: 33249114
[TBL] [Abstract][Full Text] [Related]
7. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.
Njei B; McCarty TR; Laine L
J Gastroenterol Hepatol; 2017 Apr; 32(4):852-858. PubMed ID: 27624167
[TBL] [Abstract][Full Text] [Related]
8. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
9. Hospital readmission following transjugular intrahepatic portosystemic shunt: a 14-year single-center experience.
Vozzo CF; Singh T; Bullen J; Sarvepalli S; McCullough A; Kapoor B
Gastroenterol Rep (Oxf); 2020 Apr; 8(2):98-103. PubMed ID: 32280469
[TBL] [Abstract][Full Text] [Related]
10. MELD or Sodium MELD: A Comparison of the Ability of Two Scoring Systems to Predict Outcomes After Transjugular Intrahepatic Portosystemic Shunt Placement.
Young S; Rostambeigi N; Golzarian J; Lim N
AJR Am J Roentgenol; 2020 Jul; 215(1):215-222. PubMed ID: 32432911
[No Abstract] [Full Text] [Related]
11. Inpatient Cost Assessment of Transjugular Intrahepatic Portosystemic Shunt in the USA from 2001 to 2012.
Kuei A; Lee EW; Saab S; Busuttil RW; Durazo F; Han SH; ElKabany M; McWilliams JP; Kee ST
Dig Dis Sci; 2016 Oct; 61(10):2838-2846. PubMed ID: 27349987
[TBL] [Abstract][Full Text] [Related]
12. Does advanced chronic kidney disease impact transjugular intrahepatic portosystemic shunt efficacy and safety?
Lakhoo J; Gunasekaran SS; Lokken RP; Lipnik AJ; Ray CE; Bui JT; Gaba RC
Acta Gastroenterol Belg; 2017; 80(2):243-248. PubMed ID: 29560689
[TBL] [Abstract][Full Text] [Related]
13. Transjugular intrahepatic portosystemic shunt and alfapump® system for refractory ascites in liver cirrhosis: Outcomes and complications.
Will V; Rodrigues SG; Stirnimann G; Gottardi A; Bosch J; Berzigotti A
United European Gastroenterol J; 2020 Oct; 8(8):961-969. PubMed ID: 32588789
[TBL] [Abstract][Full Text] [Related]
14. Same- vs Different-Hospital Readmissions in Patients With Cirrhosis After Hospital Discharge.
Okafor PN; Nnadi AK; Okoli O; Huang AE; Nwaiwu O
Am J Gastroenterol; 2019 Mar; 114(3):464-471. PubMed ID: 30676364
[TBL] [Abstract][Full Text] [Related]
15. Characteristics and outcomes of transjugular intrahepatic portosystemic shunt recipients in the VA Healthcare System.
Lerrigo R; Beste LA; Leipertz SL; Green PK; Lok AS; Kogut MJ; Ioannou GN
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):667-75. PubMed ID: 26886386
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
Teng D; Zuo H; Liu L; Dong J; Ding L
Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
[TBL] [Abstract][Full Text] [Related]
17. Nationwide estimates and risk factors of hospital readmission in patients with cirrhosis in the United States.
Shaheen AA; Nguyen HH; Congly SE; Kaplan GG; Swain MG
Liver Int; 2019 May; 39(5):878-884. PubMed ID: 30688401
[TBL] [Abstract][Full Text] [Related]
18. Six-month readmissions after bariatric surgery: Results of a nationwide analysis.
Rios-Diaz AJ; Metcalfe D; Devin CL; Berger A; Palazzo F
Surgery; 2019 Nov; 166(5):926-933. PubMed ID: 31399221
[TBL] [Abstract][Full Text] [Related]
19. Morbidity and mortality after transjugular intrahepatic portosystemic shunt placement in patients with cirrhosis.
Dissegna D; Sponza M; Falleti E; Fabris C; Vit A; Angeli P; Piano S; Cussigh A; Cmet S; Toniutto P
Eur J Gastroenterol Hepatol; 2019 May; 31(5):626-632. PubMed ID: 30550458
[TBL] [Abstract][Full Text] [Related]
20. The smoker's paradox in transjugular intrahepatic portosystemic shunt procedure: A national inpatient sample analysis from 2015 to 2020.
Li R; Sarin S
Clin Res Hepatol Gastroenterol; 2024 May; 48(5):102323. PubMed ID: 38537866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
